217 related articles for article (PubMed ID: 35505093)
1. Cullin-9/p53 mediates HNRNPC degradation to inhibit erastin-induced ferroptosis and is blocked by MDM2 inhibition in colorectal cancer.
Yang L; WenTao T; ZhiYuan Z; Qi L; YuXiang L; Peng Z; Ke L; XiaoNa J; YuZhi P; MeiLing J; QingYang F; GuoDong H; YueXiang W; JianMin X
Oncogene; 2022 Jun; 41(23):3210-3221. PubMed ID: 35505093
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
[TBL] [Abstract][Full Text] [Related]
3. MDM2 inhibition is synthetic lethal with PTEN loss in colorectal cancer cells via the p53-dependent mechanism.
Ren G; Yang EJ; Tao S; Mou PK; Pu Y; Chen LJ; Shim JS
Int J Biol Sci; 2023; 19(11):3544-3557. PubMed ID: 37496993
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive Agent 3,3'-Diindolylmethane Inhibits MDM2 in Colorectal Cancer Cells.
Gao X; Liu J; Cho KB; Kedika S; Guo B
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629830
[TBL] [Abstract][Full Text] [Related]
5. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
6. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer.
Choi TG; Nguyen MN; Kim J; Jo YH; Jang M; Nguyen NNY; Yun HR; Choe W; Kang I; Ha J; Tang DG; Kim SS
J Pathol; 2018 Sep; 246(1):115-126. PubMed ID: 29876924
[TBL] [Abstract][Full Text] [Related]
8. CAPG interference induces apoptosis and ferroptosis in colorectal cancer cells through the P53 pathway.
Zhao Y; Ma R; Wang C; Hu R; Wu W; Sun X; Chen B; Zhang W; Chen Y; Zhou J; Yuan P
Mol Cell Probes; 2023 Oct; 71():101919. PubMed ID: 37468079
[TBL] [Abstract][Full Text] [Related]
9. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity.
Xie Y; Zhu S; Song X; Sun X; Fan Y; Liu J; Zhong M; Yuan H; Zhang L; Billiar TR; Lotze MT; Zeh HJ; Kang R; Kroemer G; Tang D
Cell Rep; 2017 Aug; 20(7):1692-1704. PubMed ID: 28813679
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
11. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
12. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.
Jin H; Zhu M; Zhang D; Liu X; Guo Y; Xia L; Chen Y; Chen Y; Xu R; Liu C; Xi Q; Xia S; Shi T; Zhang G
Cancer Sci; 2023 Nov; 114(11):4225-4236. PubMed ID: 37661645
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis.
Lv Y; Tang W; Xu Y; Chang W; Zhang Z; Lin Q; Ji M; Feng Q; He G; Xu J
Int J Biol Sci; 2023; 19(4):1284-1298. PubMed ID: 36923931
[No Abstract] [Full Text] [Related]
14. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
[No Abstract] [Full Text] [Related]
15. Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma.
Yang Y; Luo M; Zhang K; Zhang J; Gao T; Connell DO; Yao F; Mu C; Cai B; Shang Y; Chen W
Nat Commun; 2020 Jan; 11(1):433. PubMed ID: 31974380
[TBL] [Abstract][Full Text] [Related]
16. miR-545 promotes colorectal cancer by inhibiting transferring in the non-normal ferroptosis signaling.
Zheng S; Hu L; Song Q; Shan Y; Yin G; Zhu H; Kong W; Zhou C
Aging (Albany NY); 2021 Dec; 13(24):26137-26147. PubMed ID: 34954694
[TBL] [Abstract][Full Text] [Related]
17. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
[TBL] [Abstract][Full Text] [Related]
18. USP11-mediated LSH deubiquitination inhibits ferroptosis in colorectal cancer through epigenetic activation of CYP24A1.
Duan J; Huang D; Liu C; Lv Y; Zhang L; Chang F; Zeng X; Li L; Wang W; Shao G
Cell Death Dis; 2023 Jul; 14(7):402. PubMed ID: 37414755
[TBL] [Abstract][Full Text] [Related]
19. Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein.
Yin Y; Jiang Z; Fu J; Li Y; Fang C; Yin X; Chen Y; Chen N; Li J; Ji Y; Su X; Qiu M; Huang W; Zhang B; Deng H; Dai L
Cancer Lett; 2022 Jan; 525():55-66. PubMed ID: 34562520
[TBL] [Abstract][Full Text] [Related]
20. TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway.
Liu MY; Li HM; Wang XY; Xia R; Li X; Ma YJ; Wang M; Zhang HS
Free Radic Biol Med; 2022 Mar; 182():219-231. PubMed ID: 35271998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]